克利夫兰生物实验室(CBLI.US)盘前大涨18.76%,报5.76美元。公司与美国细胞通信公司Cytocom宣布合并登记声明和委托声明。 网页链接
$克利夫兰生物实验室(CBLI)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-03 AccNo: 0001318641-17-000018 Size: 401 KB 网页链接
$克利夫兰生物实验室(CBLI)$ DEF 14A - Other definitive proxy statements Filed: 2017-03-03 AccNo: 0001318641-17-000016 Size: 704 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-02-22 AccNo: 0001318641-17-000012 Size: 21 MB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2017-02-22 AccNo: 0001318641-17-000010 Size: 178 KBItem 2.02: Results of Operations and Financial Condition 网页链接
$克利夫兰生物实验室(CBLI)$ PRE 14A - Other preliminary proxy statements Filed: 2017-02-21 AccNo: 0001318641-17-000007 Size: 704 KB 网页链接
$克利夫兰生物实验室(CBLI)$ CT ORDER - Confidential treatment order Filed: 2016-11-28 AccNo: 9999999997-16-027089 Size: 10 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-14 AccNo: 0001318641-16-000047 Size: 4 MB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2016-11-14 AccNo: 0001318641-16-000046 Size: 176 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2016-10-11 AccNo: 0001318641-16-000043 Size: 36 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$克利夫兰生物实验室(CBLI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-15 AccNo: 0001318641-16-000041 Size: 4 MB 网页链接